Abstract
The time course of the effects of intravenous or intracoronary administration of peptide leukotrienes on metabolic parameters and on systemic and coronary hemodynamics was evaluated in 15 patients with normal coronary arteries. Peptide leukotriene C4 (2 nmol given as a bolus intravenous injection) induced an early fall (at 2 min) in mean arterial pressure (P<0.02) associated with a rise in heart rate (P<0.001) and in plasma levels of epinephrine (P<0.05) and norepinephrine (P<0.005), but without significant changes in coronary blood flow or coronary vascular resistance. Mean arterial pressure, heart rate, norepinephrine, and epinephrine returned to baseline values 10 min after leukotriene C4 administration. In contrast, at 10 min post leukotriene C4, with coronary blood flow and myocardial oxygen consumption unchanged, an increase in coronary vascular resistance (P<0.05) and in myocardial oxygen extraction (P<0.01) was observed, which returned to baseline values at 20 min post leukotriene C4. Peptide leukotriene D4(3 nmol, given in the left coronary artery) induced an early (20 s) and transient fall in mean arterial pressure (P<0.001 ) paralleled by a rise in heart rate and plasma levels of epinephrine and norepinephrine, all of which returned to baseline at 10 min. Coronary vascular resistance increased at 10 and 15 min (P<0.02 and P<0.05, respectively) and myocardial oxygen extraction at 15 min (P<0.02). These results suggest that small doses of peptide leukotrienes induce both an early and transient fall in mean arterial pressure associated with secondary sympathoadrenergic activation, and a late increase in small coronary arteriolar resistance.
Similar content being viewed by others
References
Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammations. Science 1983; 220:568.
Triggiani M, Oriente A, Crescenzo G de, Marone G. Metabolism of lipid mediators in human basophils and mast cells. In: Marone G, ed. Human basophils and mast cells. Biological aspects. Basel: Karger: 1995:135.
Feldberg W, Kellaway CH. Liberation of histamine and formation of lysocithin-like substances by cobra venom. J Physiol 1938:94:187.
Marone G, Columbo M, Triggiani M, Cirillo R, Genovese A. Formisano S. Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. Biochem Pharmacol 1987; 36:13.
Hanna CJ, Bach MK, Pare PD, Schellenberg RR. Slow reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature 1981; 290:343.
Dahlèn S-E, Björk J, Hedqvist P, Arfors KE, Hammarström S, Lindgren JA, Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981 ; 78:3887.
Marom ZVI, Shelhamer JH, Bach MK, Morton DR, Kaliner M. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982; 126:449.
Corey EJ, Clark DA, Goto G, Marfat A, Mioskowski C, Samuelsson B, Hammarström S. Stereospecific total synthesis of a slow reacting substance of anaphylaxis, leukotriene C-1. J Am Chem Soc 1980;102:1436.
Feuerstein G, Zukowska-Grojec Z, Kopin IJ. Cardiovascular effects of leukotriene D4 in SHR and WKY rats. Eur J Pharmacol 1981;76: 107.
Burke JA, Levi R, Guo Z-G, Corey EJ. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. J Pharmacol Exp Ther 1982; 221:235.
Smedegård G, Hedqvist P, Dahlèn S-E, RevenÄs B, Hammarström S, Samuelsson B. Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey. Nature 1982; 295:327.
Michelassi F. Landa L, Hill RD, Lowenstein E, Watkins WD, Petkan AJ, Zappol WM. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science 1982; 217:841.
Letts LG, Piper PJ. The actions of leukotrienes C4 and D4 on guinea-pig isolated hearts. Br J Pharmacol 1982; 76:169.
Pfeffer MA, Pfeffer JM, Lewis RA, Braunwald E, Corey EJ, Austen KF. Systemic hemodynamic effects of leukotriene C4 and D4 in the rat. Am J Physiol 1983; 244:H628.
Lefer AM. Leukotrienes as mediators of ischemia and shock. Biochem Pharmacol 1986; 35:123.
Evers AS, Murphree S, Saffitz JE, Jakschik BA, Needleman P. Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction. J Clin Invest 1985; 75:992.
Feuerstein G. Leukotrienes and the cardiovascular system. Prostaglandins 1984; 27:781.
Patella V, Bouvet J-P, Marone G. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells. J Immunol 1993; 151:5685.
Patella V, MarinÒ I, Lamparter B, Arbustini E, Adt M, Marone G. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol 1995; 154:2855.
Patella V, de Crescenzo G, Marinó I, Genovese A, Adt M, Gleich GJ, Marone G. Eosinophil granule proteins activate human heart mast cells. J Immunol 1996; 157:1219.
Ganz W, Tamura K, Marcus HS, Donoso R, Yoshida S, Swan HJC. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 1971; 44:181.
Vigorito C, Poto S, Picotti GB, Triggiani M, Marone G. Effect of activation of the H1, receptor on coronary hemodynamics in man. Circulation 1986; 73:1175.
Braunwald E, Ross J Jr, Sonnenblick EH. Mechanisms of contraction of the normal and failing heart. Boston: Little Brown; 1976:130.
Picotti GB, Bulher HJ, Da Prada M. Plasma catecholamines in man and animals: assay by a new radiometric method. Experientia 1977; 33:798.
Snedecor GW, Cochran WG. Statistical methods. Iowa: The Iowa State University Press, 1980.
Wittemberg HR, Wolbling RD, Aehinghaus U, Patrono C, Peskar BM, Peskar BA. Release of slow reacting substance of anaphylaxis from guinea pig heart and vascular tissue. In: Piper PJ, ed. Leukotrienes and other lipoxygenase products. Chichester: Wiley; 1982:121–30.
Karmazyn M, Moffat MP. Calcium-ionophore stimulated release of leukotriene C4-like immunoreactive material from cardiac tissue. J Mol Cell Cardiol 1984; 16:1071.
Salari H. Immunological and non-immunological release of leukotrienes and histamine by guinea-pig heart. Immunology 1986; 58:473.
Marone G, Triggiani M, Cirillo R, Giacummo A, Hammarström S, Condorelli M. IgE-mediated activation of human heart in vitro. Agents Actions 1986; 18:194.
Patella V, de Crescenzo G, MarinÒ I, Genovese A, Adt M, Gleich GJ, Marone G. Eosinophil granule proteins are selective activators of human heart mast cells. Int Arch Allergy Immunol 1997; 113:200.
Piomelli D, Fienmark SJ, Cannon PJ. Leukotriene biosynthesis by canine and human coronary arteries. J Pharmacol Exp Ther 1987; 241:763.
Drazen JM, Austen KF, Lewis RA, Clark DA, Goto G, Marfat A, Corey EJ. Comparative airway and vascular activities of leukotriene C-1 and D in vivo and in vitro. Proc Natl Acad Sci USA 1980; 77:4354.
Zukowska-Grojec Z, Bayorth MA, Kopin IH, Feuerstein G. Leukotriene D4: cardiovascular and sympathetic effects in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKy) rats. J Pharmacol Exp Ther 1982; 223:183.
Zukowska-Grojec Z, Bayorth MA, Feuerstein G, Kopin IH. Hemodynamic effects of leukotriene D4 (LTD4) in pithed spontaneously hypertensive (SHR) rats (abstract). Circulation 1983; 68:11.
Kaijser L. Cardiovascular and pulmonary effects of leukotriene C4 in man (abstract). Eur J Resp Dis 1982; 63 [Suppl 124]:76.
Vigorito C, Russo P, Picotti GB, Chiariello M, Poto S, Marone G. Cardiovascular effects of histamine infusion in man. J Cardiovasc Pharmacol 1983; 5:531.
Burke JA, Levi R, Gleason JG. Antagonism of the cardiac effects of leukotriene C4 by compound SKF 88046: dissociation of effects on contractility and coronary flow. J Cardiovasc Pharmacol 1984; 6:122.
Cramer EB, Pologe L, Pawlowski NA, Cohn ZA, Scott WA. Leukotriene C promotes prostacyclin synthesis by human endothelial cells. Proc Natl Acad Sci USA 1983; 80:4109.
Letts LG, Cirino M, Yusko P, Fitzsimmons B, Ford-Hutchinson AW, Rokach J. Actions of synthetic leukotrienes on platelets and blood vessels in the anesthetised pig: the release of a platelet derived vasodilator. Prostaglandins 1985; 29:1049.
Roth DM, Lefer AM. Studies on the mechanism of leukotriene induced coronary artery constriction. Prostaglandins 1983; 26:573.
Panzenback MJ, Kaley G. Leukotriene D4 reduces coronary blood flow in the anesthetized dog. Prostaglandins 1983; 25:661.
Wargovich T, Mehta J, Nichols WW, Pepine CJ, Conti CR. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. J Am Coll Cardiol 1985; 6:1047.
Ezra D, Boyd LM, Feuerstein G, Goldstein RE. Coronary constriction by leukotriene C4, D4 and E4 in the intact pig heart. Am J Cardiol 1983; 51:1451.
Vatner SF, Higgins CB, Braunwald E. Effects of norepinephrine on coronary circulation and left ventricular dynamics in the conscious dog. Circ Res 1974; 34:812.
Mohrman DE, Feigl EO. Competition between sympathetic vascoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res 1978; 42:79.
Klocke FJ, Kaiser GA, Ross J Jr, Braunwald E. An intrinsic adrenergic vasodilator mechanism in the coronary vascular bed of the dog. Circ Res 1965; 16:376.
Vigorito C, Giordano A, De Caprio L, Vitale DF, Maurea N, Silvestri P, Tuccillo B, Ferrara N, Marone G, Rengo F. Effect of histamine on coronary hemodynamics in man: role of H1 and H2 receptors. J Am Coll Cardiol 1987; 10:1207.
Terashita ZI, Fukui H, Hirata M, Terao S, Ohkawa S, Nishikawa K. Kikuchi S. Coronary vasoconstriction and PGI2 release by leukotrienes in isolated guinea pig heart. Eur J Pharmacol 1981 ; 73:357.
Tomoike H, Egashiza K, Yamada A, Hayashi Y, Nakamura M. Leukotriene C4 and D4-induced diffuse peripheral constriction of swine. coronary artery accompained by ST elevation on the electrocardiogram: angiographic analysis. Circulation 1987; 76:480.
Levi R, Burke JA, Corey EJ. SRS-A, leukotrienes, and immediate hypersensitivity reactions of the heart. In: Samuelsson B, Paoletti R, eds. Leukotrienes and other lipoxygenase products. New York: Raven: 1982:215–222.
Patella V, Ciccarelli A, Lamparter-Schummert B, De Paulis A, Adt M, Marone G. Heterogeneous effects of protamine on human mast cells and basophils. Br J Anaesth 1997; 78: 724.
Bernreiter M. Electrocardiogram of patient in anaphylactic shock. JAMA 1959; 170:1628.
Smith PL, Kagey-Sobotka A, Bleeker ER, Traystman R, Kaplan AP, Gralnick H, Valentine MD, Permutt S, Lichtenstein LM. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66:1072.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vigorito, C., Giordano, A., Cirillo, R. et al. Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man. Int J Clin Lab Res 27, 178–184 (1997). https://doi.org/10.1007/BF02912454
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02912454